Sandbox g53
Jump to navigation
Jump to search
- HHV-7
Return to Top
- Most patients with infection with HHV-7 will be asymptomatic. It is unknown whether treatment in asymptomatic patients will lead to a reduction in subsequent infection. (15504215)
- Immunocompetent hosts with uncomplicated skin manifestations associated with HHV-7, particularly roseola infantum and pityriasis rosea, need only symptomatic management. (22819486)
- For HIV-positive patients, antiretroviral therapy may be advisable. (sanford)
- There are no defined circumstances that warrant specific antiviral therapy for HHV-7. (10578120)
- The most active antiviral compounds against HHV-7 are Cidofovir and Foscarnet. (11747000)